A new study opens the door to a brain anti-aging pill. Scientists have discovered a compound that can protect neurons and slow age-related cognitive decline. Still in experimental stages, it could mark a breakthrough in the fight against brain aging.
Experimental pill for a “younger” brain (RTR242)
An anti-longevity company backed by Sam Altman, Retro Biosciences, is preparing its first clinical trial with a drug called RTR242.
Business Insider
Goal: Reactivate autophagy (a cellular self-recycling process that declines with age) to remove toxic proteins that accumulate in neurons.
Business Insider
Location: Australia. They expect to begin administering it to people by the end of 2025.
Business Insider
Importance: If successful, it could not only reverse cognitive decline (such as Alzheimer’s) but also have broader effects in slowing down brain aging.
Business Insider
✨ The future of longevity may start in the brain.
